Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-31 @ 5:57 AM
Study NCT ID:
NCT07362459
Status:
RECRUITING
Last Update Posted:
2026-01-23
First Post:
2026-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
Sponsor:
Sinocelltech Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-09
First Submit QC Date:
None
Study First Post Date:
2026-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-15
Last Update Post Date:
2026-01-23
Last Update Post Date Type:
ACTUAL